HIGHLIGHTS
- What: The aim of this study was to comprehensively investigate the causal relation for IL-6 or sIL6 with sarcopenia using a two-sample Mendelian randomization approach, and to determine whether targeting these factors may be a viable approach to preventing or treating muscle loss. These findings suggest that, within the limits of the study design and the genetic instruments employed, sarcopenia traits do not exert a detectable causal influence on IL-6 or IL-6R levels. The study has several limitations that should be considered when interpreting the findings .
- Who: Interleukin and collaborators from . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.